Dec 23, 2020
Disrupting an industry is no easy task. Just ask Saundra Pelletier. As the CEO of the biopharmaceutical company Evofem, she’s making major moves in a multi-billion dollar market that hasn’t been disrupted in nearly 30 years: the contraceptive industry. Despite the fact that the global contraceptive market size was valued at $22 billion in 2019 and is projected to reach over $30 billion by 2027, there has been little innovation in the space since the 90s. But Saundra is working to change that at Evofem. The company’s latest product Phexxi, a prescription contraceptive gel, is a hormone-free option that allows women to be in control of their sexual and reproductive health. But Saundra’s not just at the forefront of disrupting the contraceptive industry on the pharmaceutical side. She’s also advocating for change in the space via the nonprofit sector as the co-founder of WomanCare Global, a nonprofit provider of health care products to women around the world. In this episode of WorkParty, we sit down with Saundra to talk about her impressive career, her commitment to giving women access to more choices, and her role as a mentor for a new generation of women coming up behind her.
Visit PHEXXI.com for full information on use and risks
Join the party on social @workparty and stay in-the-know at workparty.com
Produced by Dear Media